Synthesis and biological activity of trans-tiliroside derivatives as potent anti-diabetic agents

Molecules

Volumn 15, Issue 12, 2010, Pages 9174-9183

  Zhu, Yujin ^a,b   Zhang, Yanjun ^c   Liu, Yi ^a   Chu, Hongwan ^a   Duan, Hongquan ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b MEDICAL COLLEGE OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^c TIANJIN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Anti diabetic activity; Derivative synthesis; Novozyme435; Trans tiliroside

Indexed keywords

ANTIDIABETIC AGENT; FLAVONOID; GLUCOSE; METFORMIN; TILIROSIDE;

ARTICLE; BIOLOGICAL MODEL; CELL STRAIN HEPG2; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; INSULIN RESISTANCE; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; SYNTHESIS;

FLAVONOIDS; GLUCOSE; HEP G2 CELLS; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; MAGNETIC RESONANCE SPECTROSCOPY; METFORMIN; MODELS, BIOLOGICAL; MOLECULAR STRUCTURE;

EID: 78650647699     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15129174     Document Type: Article

References (29)

1. Dixit, M.; Tripathi, B.K.; Tamrakar, A.K.; Srivastava, A.K.; Kumar, B.; Goel, A. Synthesis of benzofuran scaffold-based potential PTP-1B inhibitors. Bioorg. Med. Chem. 2007, 15, 727-734.
2. Yue, E.W.; Wayland, B.; Douty, B.; Crawley, M.L.; McLaughlin, E.; Takvorian, A.; Wasserman, Z.; Bower, M.J.; Wei, M.; Li, Y.L.; Ala, P.J.; Gonneville, L.; Wynn, R.; Burn, T.C.; Liu, P.C.C.; Combs, A.P. Isothiazolidinone heterocycles as inhibitors of protein phosphatases: Synthesis and structure-activity relationships of a peptidescaffold. Bioorg. Med. Chem. 2006, 14, 5833-5849.
3. Murthy, V.S.; Kulkarni, V.M. Molecular modeling of protein tyrosine phosphatase 1B (PTP 1B) inhibitors. Bioorg. Med. Chem. 2002, 10, 897-906.
4. Liljebris, C.; Martinsson, J.; Tedenborg, L.; Williams, M.; Barker, E.; Duffy, J.E.S.; Nygren, A.; James, S. Synthesis and biological activity of a novel class of pyridazine analogues non-competitive reversible inhibitors of protein tyrosine phosphatase 1B (PTP 1B). Bioorg. Med. Chem. 2002, 10, 3197-3212. (Pubitemid 34855393)
5. Ma, Y.; Wen, S.Z. Efficacy of Potentilla chinesis in patients with type 2 diabetes mellitus. Chin. Trad. Herb. Drugs 2002, 33, 644-644.
6. Zhao, C.; Qiao, W.; Zhang, Y.W.; Lu, B.; Duan, H.Q. Study on anti-diabetes active fraction and consituents from Potentilla Chinesis. J .Chin. Mater. Med. 2008, 33, 680-682.
7. Sousa, E., Zanatta, L., Seifriz, I., Creczynski-Pasa, T.B., Pizzolatti, M.G.; Szpoganicz, B.; Silva, F.R. Hypoglycemic effect and antioxidant potential of kaempferol-3,7-O-(a)-dirhamnoside from bauhinia forficata leaves. J. Nat. Prod. 2004, 67, 829-832.
8. Yang, J.; Chen, H.; Zhang, L.;Wang, Q.;Lai, M.X. Anti-Diabetic Effect of Standardized Extract of Potentilla discolor Bunge and Identification of its Active Components. Drug Develop. Res. 2010, 71, 127-132.
9. Whistler, R.L.; Wolfrom, M.L. Methods in Carbohydrate Chemistry; New York and London Academic Press: New York, NY, USA, 1962; Volume 1, p. 183.
10. Tsushida, T.; Suzuki, M. Isolation of flavonoid-glycodides in onion and identification by chemical synthesis of the glycosides. Jpn. Food Sci. Technol. 1995, 42, 100-108.
11. Bruno, D.; Monica, L. A two-step efficient chemoenzymatic synthesis of flavonoid glycoside malonates. J. Nat. Prod. 1996, 5, 618-621.
12. Bruno, D.; Andrea, B. Chemo-enzymatic synthesis of 6"-O-(3-Arylprop- 2-enoyl) derivatives of the flavonol glucoside isoquercitrin. Helv. Chim. Acta 1993, 76, 2981-2991.
13. Mohamed, B.; Aziz, A.; Christian, R. Regio-and stereoselective of the major metabolite of quercetin, quercetin-3-O-b-D-glucuronide. Tetrahedron Lett. 2002, 43, 6263-6266.
14. Cauglia, F.; Canepa, P. The enzymatic synthesis of glucosylmyristate as a reaction model for general considerations on 'sugar esters' production. Bioresour. Technol. 2008, 99, 4065-4072.
15. Barbara, V.; Vedanta, M.C.; Hildebert, W. Structure elucidation and synthesis of flavonol acylglycosides. Helv. Chim. Acta 1981, 64, 1964-1967.
16. Kenji, A.; Tomomi, I.; Masamichi, A.; Masanori, I.; Akira, S.; Katsuo, I. Action of novel antidiabetic thiazolidinedione, T-174, in animal models of non-insulin-dependent diabetes mellitus (NIDDM) and in cultured muscle cells. Br. J. Pharm. 1998, 125, 429-436.
17. Li, C.G.; Ning, G.; Chen, J.L. Establishing and identifying insulin-resistance HepG2 cell line. Chin. J. Diabetes 1999, 7, 198-200.
18. Xie, W.D.; Wang, W.; Su, H.; Xing, D.M.; Pan, Y.; Du, L.J. Effect of ethanolic extracts of Ananas comosus L. leaves on insulin sensitivity in rats and HepG2. Comp. Biochem. Physiol. Part C 2006, 143, 429-435.
19. Jung, U.J.; Lee, M.K.; Park, Y.B.; Kang, M.A.; Choi, M.S. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int. J. Biochem. Cell Biol. 2006, 38, 1134-1145.
20. Mariana, T.P.; Rolffy, O.A.; Rafael, V.M.; Narender, S.; Jose, L.M.F.; Scott, P.W.; Margaret, B.; Gabriel, N.V.; Samuel, E.S.A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: Quercetin as a potential antidiabetic agent acting via 11β-Hydroxysteroid dehydrogenase type 1 inhibition. Eur. J. Med. Chem. 2010, 45, 2606-2612.
21. Atsushi. K.; Norio, N.; Kenji, T.; Isao, A.; Yasuhiro, M.; Fujiko, S.; Naoki, A.; Alison, A.W.; Robert, J.N. Structure-Activity Relationships of Flavonoids as Potential Inhibitors of Glycogen Phosphorylase. J. Agr. Food Chem. 2008, 56, 4469-4473.
22. Yoshikawa, M.; Shimada, H.; Nishida, N.; Li, Y.; Toguchida, I.; Yamahara, J.; Matsuda, H. Antidiabetic principles of natural medicines.II. Aldose reductase and alpha-glucosidase inhibitors from Brazilian natural medicine, the leaves of Myrcia multiflora DC. (Myrtaceae): Structures of myrciacitrins I and II and myrciaphenones A and B. Chem. Pharm. Bull. (Tokyo) 1998, 46, 113-119.
23. Kian, C.O.; Hoon, E.K. Insulinomimetic effects of myricetin on lipogenesis and glucose transport in rat adipocytes but not glucose transport translocation. Biochem. Pharmacol. 1996, 51, 423-429.
24. Vessal, M.; Hemmati, M. Antidiabetic effects of quercetin in streptozocin-induced diabetic rats. Comp. Biochem. Physiol. Part C 2003, 135, 357-364.
25. Tomczyk, M.; Tumanov, A.; Zaniewska, A.; Surazynski, A. The potential mechanism of tiliroside-dependent inhibition of t-butylhydroperoxide-induced oxidative stress in endometrial carcinoma cells. Planta Med. 2010, 76, 963-968.
26. Lu, Y.H.; Chen, J.; Wei, D.Z.; Wang, Z.T.; Tao, X.Y. Tyrosinase inhibitory effect and inhibitory mechanism of tiliroside from raspberry. J. Enzyme Inhib. Med. Chem. 2009, 24, 1154-1160.
27. Si, C.L.; Deng, X.J.; Liu, Z.; Kim, J.K.; Bae, Y.S. Studies on the phenylethanoid glycosides with anti-complement activity from Paulownia tomentosa var. tomentosa wood. J. Asian Nat. Prod. Res. 2008, 10, 1003-1008.
28. Jung, M.; Park, M. Acetylcholinesterase inhibition by flavonoids from Agrimonia pilosa. Molecules 2007, 12, 2130-2139.
29. Kiyofumi, N. Hisashi, M.; Mizuho, K.; Toshio, M.; Norihisa, N.; Masayuki, Y. Potent anti-obese principle from Rosa canina:Structrual requirements and mode of action of trans-tiliroside. Bioorg. Med. Chem. Lett. 2007, 17, 3059-3064.